Evidence map›Paper›PMID 41875296›Full record

ArticleJournal of innate immunity2026

<italic>Streptococcus pyogenes</italic> Infection and CD4

Anna Riegner, Nikolai Siemens

Abstract read
In one paragraph

Article in Journal of innate immunity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Anna RiegnerDepartment of Molecular Genetics and Infection Biology, University of Greifswald, Greifswald, Germany.
Nikolai SiemensDepartment of Molecular Genetics and Infection Biology, University of Greifswald, Greifswald, Germany, nikolai.siemens@uni-greifswald.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionNeutrophils are the most abundant leukocytes in human blood and a key component of host defense against Streptococcus pyogenes (group A streptococci [GAS]). They are rapidly recruited to the site of infection, where they mediate phagocytosis, degranulation, and release of neutrophil extracellular traps, thereby influencing both bacterial clearance and tissue damage. Traditionally considered short-lived effector cells, neutrophils are increasingly recognized for their immunomodulatory functions, including regulation of adaptive immunity.

methodsHuman neutrophils were infected with GAS wild-type 5448 or isogenic mutants lacking streptolysin O (Δslo) or streptolysin S (ΔsagA) and analyzed either after infection alone or after infection followed by co-culture with autologous CD4+ T cells. Neutrophil activation and T cell responses were evaluated via flow cytometry.

resultsGAS infection robustly activated neutrophils in a dose-dependent manner, driving expansion of the CD15bright/CD66bbright population and heparin-binding-protein release. Infection prompted neutrophils to acquire antigen-presenting cell (APC)-like characteristics, including HLA-DR, CD40, and CD86 expression, particularly when exposed to autologous CD4+ T cells. In 5448ΔsagA infections, neutrophils showed lower expression of costimulatory markers, and bacteria were more susceptible to intracellular killing. In co-cultures, CD4+ T cells were partially activated, as indicated by CD25 upregulation and Th1- and Th17-cell-associated cytokine release.

conclusionGAS-infected neutrophils acquire an APC-like phenotype and partially modulate CD4+ T cell activation, revealing a previously unrecognized role for infected neutrophils in shaping adaptive immunity in streptococcal infections.

Indexed as

Antigen-Presenting CellsCD4-Positive T-LymphocytesNeutrophilsStreptococcal InfectionsStreptococcus pyogenesBacterial ProteinsCell CommunicationCells, CulturedCoculture TechniquesHumansLymphocyte ActivationNeutrophil ActivationPhenotypeStreptolysinsBacterial Proteinsstreptolysin Ostreptolysin SStreptolysinsAntigen presentationNeutrophilsStreptococcus pyogenesStreptolysin ST cells

Identifiers

PMID41875296
PMCPMC13200839

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.